Percutaneous injection of sclerosant agents as an effective treatment for cystic malformations of the head and neck.

Head and neck cystic malformation Interventional radiology Percutaneous sclerotherapy

Journal

Oral and maxillofacial surgery
ISSN: 1865-1569
Titre abrégé: Oral Maxillofac Surg
Pays: Germany
ID NLM: 101319632

Informations de publication

Date de publication:
23 Jan 2024
Historique:
received: 06 07 2023
accepted: 14 01 2024
medline: 23 1 2024
pubmed: 23 1 2024
entrez: 23 1 2024
Statut: aheadofprint

Résumé

To evaluate the clinical and aesthetic outcome of percutaneous injection of sclerosant agents to treat head and neck cystic malformations (HNCM) and to assess their recurrence rate based on histology and site. Fifty-four subjects (mean age 46 years) with HNCM treated by percutaneous injection of sclerosant agents between January and December 2017 were included. Imaging and clinical data before and after the procedure were collected. Quality of Life Index, Pain Visual Analogue Scale, and Aesthetic Scale scores were measured to assess clinical and aesthetic outcomes. A size reduction of ≥ 70% assessed through the visual scale was considered significant. Of the 54 HNCM, there were 26 (48%) lymphatic malformations (LM), 13 (24%) salivary epithelial duct cysts of the parotid gland, 12 (22%) salivary mucoceles, and 3 (5%) branchial cysts. A significant size reduction and a satisfactory clinical-aesthetic outcome were observed in all types of LM. The number of reinterventions was significantly associated with the number of lesions (p < 0.001). The lowest number of interventions was observed in macrocystic lymphatic malformations (average of 1.2 interventions). All salivary epithelial duct cysts showed a significant reduction in size, a satisfactory clinical-aesthetic outcome, and an average of 1.16 interventions per patient. Mucoceles had a worse response, with only 3/14 patients showing a satisfactory and long-lasting clinical outcome (average of 1.16 interventions). Treatment of branchial cysts showed the worst outcome with a limited clinical response (3/3). Percutaneous injection of sclerosant agents may be considered as a first-line treatment for LM and salivary epithelial duct cysts.

Identifiants

pubmed: 38261079
doi: 10.1007/s10006-024-01210-9
pii: 10.1007/s10006-024-01210-9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Zhou Q, Zheng JW, Mai HM, Luo QF, Fan XD, Su LX et al (2011) Treatment guidelines of lymphatic malformations of the head and neck. Oral Oncol 47(12):1105–1109
doi: 10.1016/j.oraloncology.2011.08.001 pubmed: 21906990
Vinayachandran D, Sankarapandian S (2013) Salivary duct cyst: histo-pathologic correlatioN. J Clin Imaging Sci 3(Suppl 1):3
doi: 10.4103/2156-7514.111236 pubmed: 23878772 pmcid: 3716020
Nallasivam KU, Sudha BR (2015) Oral mucocele: review of literature and a case report. J Pharm Bioallied Sci 7(Suppl 2):S731–S733
doi: 10.4103/0975-7406.163516 pubmed: 26538955 pmcid: 4606697
Coste AH, Lofgren DH, Shermetaro C (2022) Branchial cleft cyst. StatPearls, Treasure island (FL)
Gallagher JR, Martini J, Carroll S, Small A, Teng J (2022) Annual prevalence estimation of lymphatic malformation with a cutaneous component: observational study of a national representative sample of physicians. Orphanet J Rare Dis 17(1):192
doi: 10.1186/s13023-022-02336-3 pubmed: 35550604 pmcid: 9097327
Lee SY, Loll EG, Hassan AS, Cheng M, Wang A, Farmer DL (2022) Genetic and molecular determinants of lymphatic malformations: potential targets for therapy. J Dev Biol 10(1):11
doi: 10.3390/jdb10010011 pubmed: 35225964 pmcid: 8883961
Mulligan PR, Prajapati HJ, Martin LG, Patel TH (2014) Vascular anomalies: classification, imaging characteristics and implications for interventional radiology treatment approaches. Br J Radiol 87(1035):20130392
doi: 10.1259/bjr.20130392 pubmed: 24588666 pmcid: 4064609
Takeda Y, Yamamoto H (2001) Salivary duct cyst: its frequency in a certain Japanese population group (Tohoku districts), with special reference to adenomatous proliferation of the epithelial lining. J Oral Sci 43(1):9–13
doi: 10.2334/josnusd.43.9 pubmed: 11383640
Stojanov IJ, Malik UA, Woo SB (2017) Intraoral salivary duct cyst: clinical and histopathologic features of 177 cases. Head Neck Pathol 11(4):469–476
doi: 10.1007/s12105-017-0810-5 pubmed: 28349371 pmcid: 5677068
Seifert G (1992) Tumour-like lesions of the salivary glands. The new WHO classification. Pathol Res Pract 188(7):836–846
doi: 10.1016/S0344-0338(11)80241-4 pubmed: 1448373
Prasad SC, Azeez A, Thada ND, Rao P, Bacciu A, Prasad KC (2014) Branchial anomalies: diagnosis and management. Int J Otolaryngol 2014:237015
doi: 10.1155/2014/237015 pubmed: 24772172 pmcid: 3960728
Patel S, Bhatt AA (2019) Thyroglossal duct pathology and mimics. Insights Imaging 10(1):12
doi: 10.1186/s13244-019-0694-x pubmed: 30725193 pmcid: 6365310
Perkins JA, Manning SC, Tempero RM, Cunningham MJ, Edmonds JL Jr, Hoffer FA et al (2010) Lymphatic malformations: review of current treatment. Otolaryngol Head Neck Surg 142(6):795–803 e1
doi: 10.1016/j.otohns.2010.02.026 pubmed: 20493348
Legiehn GM, Heran MK (2008) Venous malformations: classification, development, diagnosis, and interventional radiologic management. Radiol Clin N Am 46(3):545–597 vi
doi: 10.1016/j.rcl.2008.02.008 pubmed: 18707962
Ha J, Yu YC, Lannigan F (2014) A review of the management of lymphangiomas. Curr Pediatr Rev 10(3):238–248
doi: 10.2174/1573396309666131209210751 pubmed: 25088344
Bourgouin P, Thomas-Chausse F, Gilbert P, Giroux MF, Perigny S, Guertin L et al (2018) Effectiveness and safety of sclerotherapy for treatment of low-flow vascular malformations of the oropharyngeal region. J Vasc Interv Radiol 29(6):809–815
doi: 10.1016/j.jvir.2017.12.028 pubmed: 29628299
Lee HJ, Kim TW, Kim JM, Kim GW, Ko HC, Kim BS et al (2017) Percutaneous sclerotherapy using bleomycin for the treatment of vascular malformations. Int J Dermatol 56(11):1186–1191
doi: 10.1111/ijd.13733 pubmed: 28869282
Horbach SE, Lokhorst MM, Saeed P, de Gouyon Matignon de Pontouraude CM, Rothova A, van der Horst CM (2016) Sclerotherapy for low-flow vascular malformations of the head and neck: a systematic review of sclerosing agents. J Plast Reconstr Aesthet Surg 69(3):295–304
doi: 10.1016/j.bjps.2015.10.045 pubmed: 26723834
Elluru RG, Balakrishnan K, Padua HM (2014) Lymphatic malformations: diagnosis and management. Semin Pediatr Surg 23(4):178–185
doi: 10.1053/j.sempedsurg.2014.07.002 pubmed: 25241095
Zhao XP, Huang ZQ, Chen WL, Wang YY, Lin ZY (2016) Percutaneous sclerotherapy of arteriovenous malformations of the face using fibrin glue combined with OK-432 and bleomycin after embolisation. Br J Oral Maxillofac Surg 54(2):187–191
doi: 10.1016/j.bjoms.2015.11.020 pubmed: 26705860
Kim MG, Kim SG, Lee JH, Eun YG, Yeo SG (2008) The therapeutic effect of OK-432 (picibanil) sclerotherapy for benign neck cysts. Laryngoscope. 118(12):2177–2181
doi: 10.1097/MLG.0b013e3181864acf pubmed: 19029851
Burckhardt CS, Anderson KL (2003) The quality of life scale (QOLS): reliability, validity, and utilization. Health Qual Life Outcomes 1:60
doi: 10.1186/1477-7525-1-60 pubmed: 14613562 pmcid: 269997
Delgado DA, Lambert BS, Boutris N, McCulloch PC, Robbins AB, Moreno MR et al (2018) Validation of digital visual analog scale pain scoring with a traditional paper-based visual analog scale in adults. J Am Acad Orthop Surg Glob Res Rev 2(3):e088
pubmed: 30211382 pmcid: 6132313
Funk W, Podmelle F, Guiol C, Metelmann HR (2012) Aesthetic satisfaction scoring - introducing an aesthetic numeric analogue scale (ANA-scale). J Craniomaxillofac Surg 40(5):439–442
doi: 10.1016/j.jcms.2011.07.018 pubmed: 21872486
Malic CC, Guilfoyle R, Courtemanche RJM, Arneja JS, Heran MKS, Courtemanche DJ (2017) Lymphatic malformation architecture: implications for treatment with OK-432. J Craniofac Surg 28(7):1721–1724
doi: 10.1097/SCS.0000000000003789 pubmed: 28834841
Luzzatto C, Midrio P, Tchaprassian Z, Guglielmi M (2000) Sclerosing treatment of lymphangiomas with OK-432. Arch Dis Child 82(4):316–318
doi: 10.1136/adc.82.4.316 pubmed: 10735841 pmcid: 1718289
Merrow AC, Gupta A, Patel MN, Adams DM (2016) 2014 revised classification of vascular lesions from the international society for the study of vascular anomalies: radiologic-pathologic update. Radiographics. 36(5):1494–1516
doi: 10.1148/rg.2016150197 pubmed: 27517361
Hancock BJ, St-Vil D, Luks FI, Di Lorenzo M, Blanchard H (1992) Complications of lymphangiomas in children. J Pediatr Surg 27(2):220–224 discussion 4-6
doi: 10.1016/0022-3468(92)90316-Y pubmed: 1564622
Gupta R, Balasubramanian D, Clark JR (2015) Salivary gland lesions: recent advances and evolving concepts. Oral Surg Oral Med Oral Pathol Oral Radiol 119(6):661–674
doi: 10.1016/j.oooo.2015.02.481 pubmed: 25840511
Bialek EJ, Jakubowski W, Zajkowski P, Szopinski KT, Osmolski A (2006) US of the major salivary glands: anatomy and spatial relationships, pathologic conditions, and pitfalls. Radiographics. 26(3):745–763
doi: 10.1148/rg.263055024 pubmed: 16702452
Batsakis JG, Raymond AK (1989) Sialocysts of the parotid glands. Ann Otol Rhinol Laryngol 98(6):487–489
doi: 10.1177/000348948909800618 pubmed: 2729835
Ogita S, Tsuto T, Nakamura K, Deguchi E, Tokiwa K, Iwai N (1996) OK-432 therapy for lymphangioma in children: why and how does it work? J Pediatr Surg 31(4):477–480
doi: 10.1016/S0022-3468(96)90478-9 pubmed: 8801295
Rho MH, Kim DW, Kwon JS, Lee SW, Sung YS, Song YK et al (2006) OK-432 sclerotherapy of plunging ranula in 21 patients: it can be a substitute for surgery. AJNR Am J Neuroradiol 27(5):1090–1095
pubmed: 16687549 pmcid: 7975734
Fukase S, Ohta N, Inamura K, Aoyagi M (2003) Treatment of ranula wth intracystic injection of the streptococcal preparation OK-432. Ann Otol Rhinol Laryngol 112(3):214–220
doi: 10.1177/000348940311200304 pubmed: 12656411
Ha EJ, Baek SM, Baek JH, Shin SY, Han M, Kim CH (2017) Efficacy and safety of ethanol ablation for branchial cleft cysts. AJNR Am J Neuroradiol 38(12):2351–2356
doi: 10.3174/ajnr.A5373 pubmed: 28970243 pmcid: 7963744
Spinelli C, Rossi L, Strambi S, Piscioneri J, Natale G, Bertocchini A et al (2016) Branchial cleft and pouch anomalies in childhood: a report of 50 surgical cases. J Endocrinol Investig 39(5):529–535
doi: 10.1007/s40618-015-0390-8
Kullendorff CM (1997) Efficacy of bleomycin treatment for symptomatic hemangiomas in children. Pediatr Surg Int 12(7):526–528
doi: 10.1007/BF01258718 pubmed: 9238123
Eivazi B, Werner JA (2014) Extracranial vascular malformations (hemangiomas and vascular malformations) in children and adolescents - diagnosis, clinic, and therapy. GMS Curr Top Otorhinolaryngol Head Neck Surg 13:Doc02
pubmed: 25587362 pmcid: 4273163

Auteurs

Ilaria Paladini (I)

Unit of Interventional Radiology, Diagnostic Department, Hospital of Parma, Via Gramsci 14, 43126, Parma, Italy.

Silvia Schirò (S)

Department of Medicine and Surgery (DiMec), University of Parma, Via gramsci 14 (43126), Parma, Italy. silvia.schiro@unipr.it.

Roberta Eufrasia Ledda (RE)

Department of Medicine and Surgery (DiMec), University of Parma, Via gramsci 14 (43126), Parma, Italy.

Ludovica Leo (L)

Department of Medicine and Surgery (DiMec), University of Parma, Via gramsci 14 (43126), Parma, Italy.

Gianluca Milanese (G)

Unit of "Scienze Radiologiche", Department of Medicine and Surgery (DiMeC), University Hospital of Parma, Parma, Italy.

Enrico Epifani (E)

Unit of Interventional Radiology, Diagnostic Department, Hospital of Parma, Via Gramsci 14, 43126, Parma, Italy.

Andrea Andreone (A)

Unit of Interventional Radiology, Diagnostic Department, Hospital of Parma, Via Gramsci 14, 43126, Parma, Italy.

Giulia Capurri (G)

Unit of Interventional Radiology, Diagnostic Department, Hospital of Parma, Via Gramsci 14, 43126, Parma, Italy.

Matteo Fantoni (M)

Neuroradiology Unit, Diagnostic Department, University Hospital of Parma, Via Volturno 39, 43125, Parma, Italy.

Andrea Gemignani (A)

Department of Medicine and Surgery (DiMec), University of Parma, Via gramsci 14 (43126), Parma, Italy.

Alessandro Gritti (A)

Maxillo-Facial Surgery Division, Head and Neck Department, University Hospital of Parma,, Parma, Italy.

Enrico Sesenna (E)

Maxillo-Facial Surgery Division, Head and Neck Department, University Hospital of Parma, Parma, Italy.

Roberto Menozzi (R)

Interventional Neuroradiology Unit, Diagnostic Department, University Hospital of Parma, Via Volturno 39, 43125, Parma, Italy.

Classifications MeSH